US Broker Ratings

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring a 197% Potential Upside in Biotech

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is capturing investor attention with its significant potential upside and the robust pipeline in the biotech sector. With its focus on developing therapies for women’s..

ClearPoint Neuro Inc. (CLPT) Investor Outlook: Unveiling a 160% Potential Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a key player in the medical device sector, has been attracting investor attention with its potential for significant upside. Trading at $9.605, the stock presents..

Manhattan Associates, Inc. (MANH) Stock Analysis: Exploring a Potential 50% Upside for Investors

Manhattan Associates, Inc. (NASDAQ: MANH), a leader in the technology sector with a focus on software applications, offers an intriguing investment opportunity. With a market capitalization of $8.33 billion, Manhattan..

UroGen Pharma Ltd. (URGN) Stock Analysis: Exploring the 92.78% Potential Upside for Investors

UroGen Pharma Ltd. (NASDAQ: URGN), a biotechnology firm specializing in innovative treatments for urothelial and specialty cancers, is capturing investor attention with a remarkable potential upside of 92.78%. With a..

Unity Software Inc. (U) Investor Outlook: Analyzing a 64% Potential Upside Amidst Volatile Tech Markets

Unity Software Inc. (NYSE: U), a prominent player in the Technology sector, is catching investor attention with a compelling potential upside of 64.02%. Despite recent market volatility, this software application..

National Research Corporation (NRC) Stock Analysis: Navigating Challenges with a Robust Dividend Yield and Strong ROE

National Research Corporation (NRC), a key player in the Healthcare sector, operates within the Health Information Services industry, providing vital analytics and insights to enhance patient and employee experiences for..

Blend Labs, Inc. (BLND) Investor Outlook: Potential 145% Upside Amidst Analyst Optimism

Blend Labs, Inc. (NYSE: BLND), a pioneering technology company in the software application sector, has captured investor attention with its innovative cloud-based platform designed for financial services firms. Headquartered in..

Porch Group, Inc. (PRCH) Stock Analysis: A Look at Its 126.80% Potential Upside in the Property & Casualty Insurance Sector

Porch Group, Inc. (NASDAQ: PRCH), a Seattle-based company specializing in software, data solutions, and insurance services related to homeownership, presents a compelling opportunity for investors seeking exposure in the property..

ReposiTrak, Inc. (TRAK) Stock Analysis: Unveiling a 101% Potential Upside with Strategic Growth in Software Solutions

ReposiTrak, Inc. (TRAK), a prominent player in the technology sector, has been gaining attention among investors due to its substantial potential upside of 101.26%. Despite its current price of $7.95,..

Alight, Inc. (ALIT) Stock Analysis: Exploring the 295% Potential Upside for This Technology Company

Alight, Inc. (NYSE: ALIT), a technology-enabled services company specializing in cloud-based employee engagement platforms, presents a compelling, albeit challenging, investment opportunity. With a market capitalization of $371.93 million, Alight operates..

Erasca, Inc. (ERAS) Stock Analysis: Navigating a 24% Potential Upside in the Precision Oncology Space

Erasca, Inc. (ERAS), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to treating RAS/MAPK pathway-driven cancers. With a..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring an 81% Potential Upside for Patient Investors

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the biotechnology industry. Despite the challenges common to biopharmaceutical companies, Vanda’s..

Dynatrace, Inc. (DT) Stock Analysis: Unveiling a Promising 23.56% Potential Upside

Dynatrace, Inc. (NYSE: DT), a leader in the technology sector, stands out for its sophisticated AI-powered observability platform, which is rapidly gaining traction across various global markets. With a market..

Agora, Inc. (API) Stock Analysis: Is the 61% Upside Potential a Game Changer for Investors?

Agora, Inc. (NASDAQ: API) presents a tantalizing opportunity for investors seeking exposure in the dynamic technology sector. With a market capitalization of $336.84 million, Agora operates in the software application..

InterDigital, Inc. (IDCC) Stock Analysis: Exploring a 31% Potential Upside Amid Strong Analyst Confidence

Investors eyeing the technology sector may find InterDigital, Inc. (NASDAQ: IDCC) particularly intriguing. Known for its robust research and development in wireless, visual, and artificial intelligence technologies, InterDigital holds a..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Potential 434% Upside Amidst Biotech Innovations

aTyr Pharma, Inc. (NASDAQ: ATYR) is carving a niche in the biotechnology sector with its innovative approach to treating fibrosis and inflammation. Headquartered in San Diego, California, this clinical-stage biotech..

AudioEye, Inc. (AEYE) Stock Report: Analysts Predict a 187.93% Upside Potential

AudioEye, Inc. (NASDAQ: AEYE), a technology firm specializing in digital accessibility solutions, is garnering significant attention in the investment community, thanks to an impressive analyst consensus predicting a potential upside..

Intuit Inc. (INTU) Stock Analysis: Exploring a 36.56% Potential Upside with Robust Revenue Growth

Intuit Inc. (NASDAQ: INTU), a leading player in the Technology sector, offers a compelling investment narrative with its strong market position in the Software – Application industry. With a market..

Nerdy Inc. (NRDY) Investor Outlook: Navigating a 153% Upside Potential Amidst Market Volatility

For investors eyeing the technology sector, Nerdy Inc. (NASDAQ: NRDY) presents a compelling case with substantial upside potential. Despite recent challenges, including a stock price that currently hovers at $0.822,..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unveiling a 106.91% Upside Potential

Investors seeking opportunities in the biotechnology sector may want to keep a close eye on Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotech company with a promising DNA-directed RNA interference..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds